Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application is a continuation of its earlier patent, and broadens its claims by guaging the drugs effects against a subject's own baseline, as well as on a patient population basis. An earlier application granted last week had been guaged only against a placebo control group.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Wed, 8:45AM)
at Zacks.com (Mon, 9:13AM)
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Feb 28, 2014)
at MarketWatch.com (Jan 21, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs